FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 56 filers reported holding FENNEC PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,963,369 | -15.0% | 261,434 | -0.0% | 0.00% | – |
| Q2 2023 | $2,308,913 | +13.6% | 261,485 | -20.1% | 0.00% | – |
| Q1 2021 | $2,032,000 | -20.0% | 327,151 | -4.1% | 0.00% | – |
| Q4 2020 | $2,541,000 | +27.7% | 341,051 | +3.9% | 0.00% | – |
| Q3 2020 | $1,990,000 | -15.5% | 328,306 | +16.5% | 0.00% | – |
| Q2 2020 | $2,354,000 | +189.9% | 281,868 | +68.4% | 0.00% | – |
| Q1 2019 | $812,000 | -21.4% | 167,372 | +3.4% | 0.00% | – |
| Q4 2018 | $1,033,000 | -19.2% | 161,918 | +4.0% | 0.00% | – |
| Q3 2018 | $1,278,000 | -17.5% | 155,725 | +5.0% | 0.00% | – |
| Q2 2018 | $1,549,000 | – | 148,325 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic GP LLC | 2,407,357 | $18,079,251 | 17.55% |
| Solas Capital Management, LLC | 1,725,567 | $12,959,008 | 9.07% |
| DG Capital Management, LLC | 1,143,099 | $8,584,673 | 4.70% |
| HARBERT FUND ADVISORS, INC. | 466,869 | $3,506,186 | 2.56% |
| AIGH Capital Management LLC | 373,526 | $2,805,180 | 1.33% |
| Southpoint Capital Advisors LP | 4,077,214 | $30,619,877 | 0.68% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $525,700 | 0.68% |
| Worth Venture Partners, LLC | 92,636 | $695,696 | 0.41% |
| Lion Point Capital, LP | 110,000 | $826,100 | 0.37% |
| 683 Capital Management, LLC | 300,000 | $2,253,000 | 0.18% |